✦ LIBER ✦

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

✍ Scribed by Czyz, Anna; Romejko-Jarosinska, Joanna; Knopinska-Posluszny, Wanda; Nowicki, Adam; Lojko-Dankowska, Anna; Gil, Lidia; Dytfeld, Dominik; Walewski, Jan; Hellmann, Andrzej; Komarnicki, Mieczyslaw

Book ID: 120259133
Publisher: Informa plc
Year: 2012
Tongue: English
Weight: 250 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2012.734612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB